The Worldwide Nucleic Acid Sample Preparation Industry is Projected to Reach $11.2 Billion by 2032 - ResearchAndMarkets.com

2023-02-07
Business Wire
DUBLIN--(BUSINESS WIRE)--The "Nucleic Acid Sample Preparation Market - A Global and Regional Analysis: Focus on Product, Workflow, Technology, Therapeutic Area, Application, End User, and Region - Analysis and Forecast, 2022-2032" report has been added to ResearchAndMarkets.com's offering.
'Nucleic Acid Sample Preparation Market - A Global and Regional Analysis: Focus on Product, Workflow, Technology, Therapeutic Area, Application, End User, and Region - Analysis and Forecast, 2022-2032'
The global nucleic acid sample preparation market is projected to reach $11,200.5 million by 2032 from $4,213.0 million in 2022, growing at a CAGR of 10.27% during the forecast period 2022-2032.
The growth in the global nucleic acid sample preparation market is expected to be driven by the increased use of nucleic acid molecules in several therapeutic areas.
In addition, the increased demand for downstream applications such as next-generation sequencing (NGS) and others and the advancement in nucleic acid extraction/isolation techniques have driven the growth of the nucleic acid sample preparation market.
Market Lifecycle Stage
The global nucleic acid sample preparation market is in progressing phase. To meet the growing need for timely diagnostic information and targeted patient treatment, several molecular procedures, including automated nucleic acid sample preparation workstations, have been developed.
In addition, sample preparation is essential in precision medicine because it assures the safe and successful use of tailored therapies.
The market offers a range of universal products with varied maximum throughputs, innovations, time durations, and other qualities, and companies are searching for innovative methods to distinguish themselves. Additionally, manufacturers began to produce application-specific nucleic acid purification devices and liquid handlers in recent years.
Impact
One of the main reasons for the anticipated expansion of the nucleic acid sample preparation market in the upcoming years is the rise in the use of nucleic acid molecules in several therapeutic areas. Sample preparation is typically an important phase in the accurate analysis of nucleic acids. Nuclease protection is one of the most important aspects to consider while processing nucleic acid samples. Nucleic acid extraction and isolation is the first stage in the area of molecular biology research, followed by recombinant procedures.
Market Segmentation
Segmentation 1: by Product
Systems
Consumables
Accessories and Components
Segmentation 2: by Workflow
Sample Extraction/Isolation
Sample Quantification
Quality Control
Fragmentation
Target Enrichment
Library Quantification
Pooling
Segmentation 3: by Technology
Spin-Column Based Technology
Magnetic-Bead Based Technology
Segmentation 4: by Therapeutic Area
Oncology
Human Genetics/Population Genetics
Others
Segmentation 5: by Application
Genomics
Proteomics
Other Applications
Segmentation 6: by End User
Academic and Research Institutions
Clinical and Diagnostic Laboratories
Other End Users
Segmentation 7: by Region
North America
Europe
Asia Pacific
Latin America
Rest-of-the-World
Recent Developments in the Global Nucleic Acid Sample Preparation Market
In June 2022, Hamilton Company. and Bionano Genomics created a Long String VANTAGE, a brand-new DNA extraction automation product. Ultra-high molecular weight (UHMW) DNA can be extracted with the instrument and used for optical genome mapping (OGM). As a requirement for the sample preparation workflow at Bionano Genomics, high-quality and quantity UHMW DNA extraction is required.
In November 2022, RevoluGen, a U.K.-based genomics company, announced that it had entered into an agreement with Tecan Trading AG, a pioneer and industry leader in laboratory automated processes, for the production and supply of Tecan's 96-well filter plates for use in RevoluGen's automated Fire Monkey High Molecular Weight (HMW)-DNA extraction kits.
In June 2021, Agilent Technologies, Inc. launched the SureSelect Human All Exon V8. This new exome design offers thorough content and current coverage of protein-coding areas from RefSeq, CCDS, and GENCODE. Additionally, it includes exons that are challenging to capture and the TERT promoter, which is neglected by competing exomes. The new design offers content flexibility to satisfy the demands of customers in three options, i.e., standard exome sequencing (Exome v8), translational research (v8 UTR Plus), and clinical research sequencing (v8 Clinical Plus).
In August 2022, the introduction of the QIAseq Targeted DNA Pro Panels and the QIAseq UPXome RNA Library Kit, both of which have set new benchmarks in sample preparation for determining their nucleic acid sequences, allowed QIAGEN N.V. to announce the extension of its next-generation sequencing (NGS) portfolio. The time required for library preparation of DNA samples by researchers is cut in half to six hours due to the QIAseq Targeted DNA Pro Panels' enhanced chemistry.
Demand - Drivers and Limitations
The following are the demand drivers for the global nucleic acid sample preparation market:
Increasing Use of Nucleic Acid Molecules in Various Therapeutic Areas
Advancement in the Nucleic Acid Extraction/Isolation Techniques
Advantages of Automated Sample Preparation Workstations
Increasing Demand for Downstream Applications such as Next-Generation Sequencing (NGS)
The market is expected to face some limitations due to the following challenges:
High Cost of Automated Workstations
Rigid Regulatory Standards
Key Companies Profiled
BIONEER CORPORATION.
Endress+Hauser Group Services AG (Analytik Jena GmbH)
OPENTRONS
For more information about this report visit https://www.researchandmarkets.com/r/vlrv33-acid?w=4
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
机构
适应症
靶点
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。